MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 40 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $390,292 | +17.2% | 12,351 | -4.0% | 0.00% | +50.0% |
Q2 2023 | $332,947 | +56.1% | 12,870 | +44.9% | 0.00% | +100.0% |
Q1 2023 | $213,322 | +25.7% | 8,881 | +2.0% | 0.00% | 0.0% |
Q4 2022 | $169,728 | -5.7% | 8,704 | +1.4% | 0.00% | 0.0% |
Q3 2022 | $180,000 | +24.1% | 8,583 | +15.4% | 0.00% | 0.0% |
Q2 2022 | $145,000 | +271.8% | 7,436 | +315.7% | 0.00% | – |
Q1 2022 | $39,000 | +25.8% | 1,789 | -6.6% | 0.00% | – |
Q4 2021 | $31,000 | -20.5% | 1,916 | -2.9% | 0.00% | – |
Q3 2021 | $39,000 | +11.4% | 1,973 | -2.3% | 0.00% | – |
Q2 2021 | $35,000 | -49.3% | 2,020 | -42.1% | 0.00% | – |
Q1 2021 | $69,000 | +30.2% | 3,490 | +14.0% | 0.00% | – |
Q4 2020 | $53,000 | -11.7% | 3,061 | -1.5% | 0.00% | – |
Q3 2020 | $60,000 | -3.2% | 3,109 | -2.2% | 0.00% | – |
Q2 2020 | $62,000 | +44.2% | 3,180 | +3.1% | 0.00% | – |
Q1 2020 | $43,000 | +4.9% | 3,083 | +83.1% | 0.00% | – |
Q4 2019 | $41,000 | +141.2% | 1,684 | -0.9% | 0.00% | – |
Q3 2019 | $17,000 | – | 1,699 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |